tradmap

EW Edwards Lifesciences

$89.78 -1.16%

Updated

S&P 500 Companies

Held by SPYVOOIVV

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Edwards Lifesciences (EW) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $51.7 billion. Shares last traded at $89.78, 6.8% below their 52-week high. Over the past year the stock is up 10.5%. EW trades at a price-to-earnings ratio of 51.49, above the Orthopedic, Prosthetic & Surgical Appliances & Supplies median of 27.46. Net profit margin is 15.4%, above the peer median of 5.3%. Revenue grew 11.5% year over year.

Market Cap
$51.7B
Shares Out
576.4M
EPS (TTM)
$4.58
P/E Ratio
19.60
P/S Ratio
7.95
P/B Ratio
4.87
Dividend / Share
Dividend Yield
52-Week High
$96.28
52-Week Low
$72.01
Volume
82,690
Avg Vol (3m)
241,670.714

Performance

1W
-0.17%
1M
+0.90%
3M
+2.69%
6M
+7.00%
YTD
+5.21%
1Y
+10.51%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
48.73
SMA (50)
$89.69
SMA (200)
$84.95
Price vs SMA50
+0.09%
Price vs SMA200
+5.68%
ATR (14)
$2.03

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$6.5B
Net Income
$1.0B
Gross Margin
77.8%
Operating Margin
22.3%
Net Margin
15.4%
Return on Equity
9.5%
Return on Assets
7.2%
Current Ratio
4.52
Debt / Equity
0.06
Revenue Growth (YoY)
+11.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $1.07 2026-08-04
Q1 2026 $0.66 2026-05-06
FY 2025 $1.83 2026-02-25
Q3 2025 $1.67 2025-11-05
Q2 2026 $1.18 2026-08-04
Q1 2026 $0.61 2026-05-06

Full earnings history →

Orthopedic, Prosthetic & Surgical Appliances & Supplies peers

EW vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Updated

P/E vs peers
51.49 / 27.46 med
+88% premium
P/S vs peers
7.95 / 2.90 med
+174% premium
Net margin vs peers
15.4% / 5.3% med
above median
1–14 of 14
ISRGIntuitive Surgical$130.7B41.6411.8428.4%-0.51%
EWEdwards Lifesciences$51.7B51.497.9515.4%-1.16%
STESteris$22.1B27.463.6613.3%-1.52%
ZBHZimmer Biomet$18.9B23.382.229.5%-0.60%
ALGNAlign Technology$11.4B27.462.7410.0%+0.45%
MSAMsa Safety Inc$7.2B23.083.7216.1%-0.34%
ESTAEstablishment Labs Holdings Inc.$2.2B-55.448.77-15.8%-3.60%
CDRECadre Holdings, Inc.$1.3B35.471.875.3%+4.26%
ENOVEnovis Corp$1.1B-1.010.49-48.0%-4.03%
AVRAnteris Technologies Global Corp.$851M-8.22379.49+1.51%
SMTISanara MedTech Inc.$319M-9.952.90-29.2%-0.33%
CNXUConexeu Sciences Inc.$149M-5.78%
INGNInogen Inc$144M-5.870.48-8.1%+0.93%
LAKELAKELAND INDUSTRIES INC$121M-4.510.63-14.0%+3.01%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.